CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum

Vaccine

Volumn 21, Issue 23, 2003, Pages 3307-3318

  Zhang, Yan ^a,c   Palmer, Guy H ^a   Abbott, Jeffrey R ^a   Howard, Chris J ^b   Hope, Jayne C ^b   Brown, Wendy C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c Animal Disease Diagnostic Laboratory   (United States)

Author keywords

Adjuvants; CpG ODN; Interleukin 12

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE 2006; OUTER MEMBRANE PROTEIN; RICKETTSIA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CATTLE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA TRANSCRIPTION; TH1 CELL;

EID: 0038797776     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00176-2     Document Type: Article

References (64)

1. Heeg K., Sparwasser T., Lipford G.B., Hacker H., Zimmermann S., Wagner H. Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells. Eur. J. Clin. Microbiol. Infect. Dis. 17(7):1998;464-469.
2. Hemmi H., Takeuchi O., Kawai T.et al. A toll-like receptor recognizes bacterial DNA. Nature. 408(6813):2000;740-745.
3. Bauer S., Kirschning C.J., Hacker H.et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U.S.A. 98(16):2001;9237-9242.
4. Klinman D.M., Takeshita F., Gursel I.et al. CpG DNA: recognition by and activation of monocytes. Microbes Infect. 4(9):2002;897-901.
5. Krieg A.M. The role of CpG motifs in innate immunity. Curr. Opin. Immunol. 12(1):2000;35-43.
6. Hartmann G., Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164(2):2000;944-953.
7. Krieg A.M., Wagner H. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today. 21(10):2000;521-526.
8. Brown W.C., Estes D.M., Chantler S.E., Kegerreis K.A., Suarez C.E. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells. Infect. Immun. 66(11):1998;5423-5432.
9. Zhang Y., Shoda L.K., Brayton K.A., Estes D.M., Palmer G.H., Brown W.C. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. J. Interferon Cytokine Res. 21(10):2001;871-881.
10. Shoda L.K., Kegerreis K.A., Suarez C.E., Mwangi W., Knowles D.P., Brown W.C. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-α, and NO production by bovine macrophages. J. Leukoc. Biol. 70(1):2001;103-112.
11. Brown W.C., Corral R.S. Stimulation of B lymphocytes, macrophages, and dendritic cells by protozoan DNA. Microbes Infect. 4(9):2002;969-974.
12. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186(10):1997;1623-1631.
13. Davis H.L., Weeratna R., Waldschmidt T.J. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160(2):1998;870-876. [published erratum appears in J Immunol 1999;162(5):3103].
14. Roman M., Martin-Orozco E., Goodman J.S.et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3(8):1997;849-854.
15. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187(7):1998;1145-1150.
16. Sparwasser T., Koch E.S., Vabulas R.M.et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28(6):1998;2045-2054.
17. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 96(16):1999;9305-9310.
18. Weeratna R.D., McCluskie M.J., Xu Y., Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine. 18(17):2000;1755-1762.
19. Jones T.R., Obaldia N. III, Gramzinski R.A.et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine. 17(23-24):1999;3065-3071.
20. Davis H.L., Suparto I.I., Weeratna R.R.et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine. 18(18):2000;1920-1924.
21. Hartmann G., Weeratna R.D., Ballas Z.K.et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164(3):2000;1617-1624.
22. McCluskie MJ, Weeratna RD, Davis HL. Comparison of CpG DNA with other adjuvants for vaccination against hepatitis B virus. In: Raz E, editor. Microbial DNA and host immunity. La Jolla: Humana Press; 2002. p. 229-38.
23. Brown W.C., Palmer G.H. Designing blood-stage vaccines against Babesia bovis and B. bigemina. Parasitol. Today. 15(7):1999;275-281.
24. Palmer G.H., Rurangirwa F.R., Kocan K.M., Brown W.C. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today. 15(7):1999;281-286.
25. Sun W., Ijdo J.W., Telford S.R. Jr.et al. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Invest. 100(12):1997;3014-3018.
26. Shoda L.K., Palmer G.H., Florin-Christensen J., Florin-Christensen M., Godson D.L., Brown W.C. Babesia bovis-stimulated macrophages express interleukin-1β, interleukin-12, tumor necrosis factor-α, and nitric oxide and inhibit parasite replication in vitro. Infect. Immun. 68(9):2000;5139-5145.
27. Akkoyunlu M., Fikrig E. γ-interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68(4):2000;1827-1833.
28. Banerjee R., Anguita J., Fikrig E. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect. Immun. 68(7):2000;4361-4362.
29. Brown W.C. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection. Vet. Parasitol. 101(3-4):2001;233-248.
30. + T cell responses induced by DNA vaccination of outbred animals. J. Immunol. 169(7):2002;3837-3846.
31. Tuo W., Palmer G.H., McGuire T.C., Zhu D., Brown W.C. Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale. Infect. Immun. 68(1):2000;270-280.
32. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157(5):1996;1840-1845.
33. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84(2):1997;185-193.
34. Jakob T., Walker P.S., Krieg A.M., von Stebut E., Udey M.C., Vogel J.C. Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses. Int. Arch. Allergy Immunol. 118(2-4):1999;457-461.
35. Palmer G.H., McGuire T.C. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J. Immunol. 133(2):1984;1010-1015.
36. Oberle S.M., Palmer G.H., Barbet A.F., McGuire T.C. Molecular size variations in an immunoprotective protein complex among isolates of Anaplasma marginale. Infect. Immun. 56(6):1988;1567-1573.
37. Torioni de Echaide S., Knowles D.P., McGuire T.C., Palmer G.H., Suarez C.E., McElwain T. Detection of cattle naturally infected with Anaplasma marginale in a region of endemicity by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5. J. Clin. Microbiol. 36(3):1998;777-782.
38. van Eijk M.J., Stewart-Haynes J.A., Lewin H.A. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23(6):1992;483-496.
39. + T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3. Infect. Immun. 66(11):1998;5414-5422.
40. + T lymphocyte epitopes that elicit strong recall responses. J. Immunol. 166(2):2001;1114-1124.
41. Bennett S., Riley E.M. The statistical analysis of data from immunoepidemiological studies. J. Immunol. Methods. 146(2):1992;229-239.
42. Shoda L.K., Zarlenga D.S., Hirano A., Brown W.C. Cloning of a cDNA encoding bovine interleukin-18 and analysis of IL-18 expression in macrophages and its IFN-γ-inducing activity. J. Interferon. Cytokine Res. 19(10):1999;1169-1177.
43. Mena A., Ioannou X.P., Van Kessel A.et al. Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR. J. Immunol. Methods. 263(1-2):2002;11-21.
44. SAS Institute I. SAS/STAT User's Guide, Version 6, vol. 2. Cary (NC): SAS Institute; 1990. p. 846.
45. Zar JH. Biostatistical analysis. 3rd ed. New Jersey. Englewood Cliffs (NJ): Prentice-Hall; 1996.
46. Rankin R., Pontarollo R., Ioannou X.et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11(5):2001;333-340.
47. Pontarollo R.A., Rankin R., Babiuk L.A.et al. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 84(1-2):2002;43-59.
48. Gately M.K., Renzetti L.M., Magram J.et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:1998;495-521.
49. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:2002;709-760.
50. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity. 5(4):1996;303-310.
51. Jankovic D., Caspar P., Zweig M.et al. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159(5):1997;2409-2417.
52. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., Goddeeris B.M. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet. Immunol. Immunopathol. 86(1-2):2002;31-41.
53. Liang H., Lipsky P.E. The response of human B lymphocytes to oligodeoxynucleotides. Springer Semin. Immunopathol. 22(1-2):2000;63-75.
54. Manetti R., Annunziato F., Tomasevic L.et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukin-12x. Eur. J. Immunol. 25(9):1995;2656-2660.
55. Estes D.M., Tuo W., Brown W.C., Goin J. Effects of type I/type II interferons and transforming growth factor-β on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression. Immunology. 95(4):1998;604-611.
56. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature. 413(6857):2001;732-738.
57. Estes D.M., Closser N.M., Allen G.K. IFN-γ stimulates IgG2 production from bovine B cells costimulated with anti-μ and mitogen. Cell Immunol. 154(1):1994;287-295.
58. Estes D.M., Hirano A., Heussler V.T., Dobbelaere D.A., Brown W.C. Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro. Cell Immunol. 163(2):1995;268-279.
59. + T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect. Immun. 67(1):1999;155-164.
60. Estes D.M., Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet. Immunol. Immunopathol. 90(1-2):2002;1-10.
61. Brown W.C., Davis W.C., Tuo W. Human interleukin-12 upregulates proliferation and interferon-γ production by parasite antigen-stimulated Th cell clones and γ/δ T cells of cattle. Ann. N. Y. Acad. Sci. 795:1996;321-324.
62. + T cells of cattle: IL-12 enhances IFN-γ production, whereas IL-4 has marginal effects on cytokine expression. J. Interferon Cytokine Res. 19(7):1999;741-749.
63. Faquim-Mauro E.L., Coffman R.L., Abrahamsohn I.A., Macedo M.S. Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol. 163(7):1999;3572-3576.
64. Bajer A.A., Garcia-Tapia D., Jordan K.R.et al. Peripheral blood derived bovine dendritic cells promote IgG1-restricted B cell responses in vitro. J. Leukoc. Biol. 73(1):2003;100-106.